Catalyst Wire Dossier Catalyst Wire Dossier

House Dust Mite Allergen Extract

House dust mite allergen extract · Allergopharma GmbH & Co. KG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for House Dust Mite Allergen Extract, covering 2013-02-11 to 2013-02-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis [Phase 4]

See pricing